EVC
TEVA icon

Eidelman Virant Capital’s Teva Pharmaceuticals TEVA Stock Holding History

Eidelman Virant Capital’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$380K Hold
46,718
– – 0.28% 92
2022
Q2 		$329K Hold
46,718
– – 0.24% 103
2022
Q1 		$438K Hold
46,718
– – 0.24% 98
2021
Q4 		$374K Buy
46,718
+26,300
+129% +$237K 0.14% 123
2021
Q3 		$201K Sell
20,418
-40,000
-66% -$375K 0.08% 170
2021
Q2 		$600K Hold
60,418
– – 0.23% 89
2021
Q1 		$694K Buy
+60,418
New +$693K 0.28% 84

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Eidelman Virant Capital's TEVA Position: Q3 2022 in Review

Eidelman Virant Capital held its Teva Pharmaceuticals (TEVA) position steady in Q3 2022 at 46,718 shares worth $380K. The position accounts for 0.28% of the portfolio, ranked #92.

Eidelman Virant Capital first reported a position in TEVA in Q1 2021 and has held it in 7 quarters since. The position peaked at $694K in Q1 2021. 430 funds tracked by Wall St. Rank hold TEVA as of Q3 2022.

  • Eidelman Virant Capital held 46,718 shares of Teva Pharmaceuticals worth $380K as of Q3 2022.
  • Eidelman Virant Capital left its Teva Pharmaceuticals share count unchanged in Q3 2022.
  • Teva Pharmaceuticals made up 0.28% of Eidelman Virant Capital's portfolio in Q3 2022, its #92 holding.
  • Eidelman Virant Capital first reported a position in Teva Pharmaceuticals in Q1 2021 and has held it in 7 quarters since.
  • Eidelman Virant Capital's Teva Pharmaceuticals position peaked at $694K in Q1 2021.
  • 430 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2022.

Based on Eidelman Virant Capital's 13F filing for Q3 2022, filed 25 Oct 2022.